Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M. Massano D, et al. Among authors: vinti l. Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2. Pediatr Blood Cancer. 2022. PMID: 35656841
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Pillon M, Mussolin L, Carraro E, Conter V, Aricò M, Vinti L, Garaventa A, Piglione M, Buffardi S, Sala A, Santoro N, Lo Nigro L, Mura R, Tondo A, Casale F, Farruggia P, Pierani P, Cesaro S, d'Amore ES, Basso G. Pillon M, et al. Among authors: vinti l. Br J Haematol. 2016 Nov;175(3):467-475. doi: 10.1111/bjh.14240. Epub 2016 Jul 8. Br J Haematol. 2016. PMID: 27392319 Free article.
HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.
De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M. De Re V, et al. Among authors: vinti l. Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285306 Free PMC article.
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.
Pomari E, Lovisa F, Carraro E, Primerano S, D'Amore ESG, Bonvini P, Nigro LL, Vito R, Vinti L, Farruggia P, Pillon M, Basso G, Basso K, Mussolin L. Pomari E, et al. Among authors: vinti l. Oncotarget. 2017 Nov 11;8(64):107886-107898. doi: 10.18632/oncotarget.22386. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296210 Free PMC article.
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.
Mussolin L, Lovisa F, Gallingani I, Cavallaro E, Carraro E, Damanti CC, Vinti L, Sala A, Micalizzi C, Santoro N, Piglione M, Cellini M, Buffardi S, Buldini B, D'Amore ESG, Biffi A, Pillon M. Mussolin L, et al. Among authors: vinti l. Br J Haematol. 2020 May;189(3):e108-e111. doi: 10.1111/bjh.16531. Epub 2020 Feb 20. Br J Haematol. 2020. PMID: 32080837 Free article. No abstract available.
Comparison of Hodgkin's Lymphoma in Children and Adolescents. A Twenty Year Experience with MH'96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols.
Burnelli R, Fiumana G, Rondelli R, Pillon M, Sala A, Garaventa A, D'Amore ESG, Sabattini E, Buffardi S, Bianchi M, Vinti L, Zecca M, Muggeo P, Provenzi M, Farruggia P, Rossi F, D'Amico S, Facchini E, Bernasconi S, De Santis R, Casini T, Porta F, D'Alba I, Mura R, Verzegnassi F, Sau A, Cesaro S, Perruccio K, Cellini M, Bertolini P, Sperlì D, Pericoli R, Galimberti D, Civino A, Mascarin M. Burnelli R, et al. Among authors: vinti l. Cancers (Basel). 2020 Jun 18;12(6):1620. doi: 10.3390/cancers12061620. Cancers (Basel). 2020. PMID: 32570974 Free PMC article.
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
Brivio E, Locatelli F, Lopez-Yurda M, Malone A, Díaz-de-Heredia C, Bielorai B, Rossig C, van der Velden VHJ, Ammerlaan ACJ, Thano A, van der Sluis IM, den Boer ML, Chen Y, Sleight B, Brethon B, Nysom K, Sramkova L, Øra I, Vinti L, Chen-Santel C, Zwaan CM. Brivio E, et al. Among authors: vinti l. Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848. Blood. 2021. PMID: 33067614 Free PMC article. Clinical Trial.
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
Lovisa F, Gallingani I, Varotto E, Pasin C, Carraro E, Michielotto B, Garbin A, Damanti CC, Pizzi M, d'Amore ESG, Piglione M, Muggeo P, Buffardi S, Vinti L, Folsi VM, Onofrillo D, Biffi A, Buldini B, Pillon M, Mussolin L. Lovisa F, et al. Among authors: vinti l. Diagnostics (Basel). 2021 Sep 1;11(9):1594. doi: 10.3390/diagnostics11091594. Diagnostics (Basel). 2021. PMID: 34573936 Free PMC article.
61 results